[Construction of hepatitis C virus-NS3 Th1 plasmid vaccine based on MHC class II-associated invariant chain peptide substitution].
Gao
Ming
M
Department of Transfusion, Lanzhou General Hospital, Lanzhou Command, Lanzhou, China. 6603gaoming@163.com
Wang
Hai-ping
HP
Lu
Yuan
Y
Zhou
Yong
Y
Wang
Yan-ning
YN
Zhan
Lin-sheng
LS
Wang
Qaun-li
QL
D000818:Animals; D000944:Antigens, Differentiation, B-Lymphocyte / Q000276:immunology*; D015870:Gene Expression; D016174:Hepacivirus / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D018417:Th1 Cells / Q000276:immunology / Q000378:metabolism*; D014761:Viral Hepatitis Vaccines / Q000235:genetics* / Q000276:immunology
D000944:Antigens, Differentiation, B-Lymphocyte; D000949:Histocompatibility Antigens Class II; D014761:Viral Hepatitis Vaccines; C045084:invariant chain